AKESF Financials: Akeso, Inc. AI Analysis



Financials

AKESF Financial

Akeso, Inc.

0%

$0

At close: Sep 02, 16:00:00 GMT-4

0%

$0

Post-market: Sep 02, 19:37:58 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is AKESO INC.?

Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company is headquartered in Zhongshan, Guangdong and currently employs 3,529 full-time employees. The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.

Features

Markets

News

Breakdown	TTM	06/30/2026	03/31/2026	12/31/2025	09/30/2025	06/30/2025
Revenue	6,492	123	3,049	1,988	1,332	-319
Revenue Growth (YoY)	10%	-139%	-20%	784%	-39%	-125%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	5,223	1,309	1,305	1,335	1,274	1,161
Research & Development	--	--	--	--	--	--
Operating Expenses	6,393	-524	3,277	2,321	1,319	-685
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-21	665	-400	-358	72	189
Income Tax Expense	-166	5	20	-172	-19	4
Net Income	59	644	-435	-215	65	168
Net Income Growth	-554%	283%	1,143%	-164%	-113.99%	-36%
Shares Outstanding (Diluted)	70.29	70.29	69.74	68.57	70.27	71.93
Shares Change (YoY)	-2%	-2%	-5%	-9%	-6%	-7%
EPS (Diluted)	0.83	9.16	-6.23	-3.13	0.92	2.33
EPS Growth	-561%	292%	1,209%	-170%	-113.99%	-32%
Free Cash Flow	5,885	1,849	1,045	1,621	1,370	1,173
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	0.97%	526.01%	-7.47%	-18.56%	0.97%	-114.73%
Profit Margin	0.9%	523.57%	-14.26%	-10.81%	4.87%	-52.66%
Free Cash Flow Margin	90.65%	1,503.25%	34.27%	81.53%	102.85%	-367.71%
EBITDA	--	--	--	--	--	--
EBITDA Margin	--	--	--	--	--	--
D&A For EBITDA	--	--	--	--	--	--
EBIT	63	647	-228	-369	13	366
EBIT Margin	0.97%	526.01%	-7.47%	-18.56%	0.97%	-114.73%
Effective Tax Rate	790.47%	0.75%	-5%	48.04%	-26.38%	2.11%

Breakdown

TTM

06/30/2026

03/31/2026

12/31/2025

09/30/2025

06/30/2025

Revenue

6,492

123

3,049

1,988

1,332

-319

Revenue Growth (YoY)

10%

-139%

-20%

784%

-39%

-125%

Cost of Revenue

Gross Profit

Selling, General & Admin

5,223

1,309

1,305

1,335

1,274

1,161

Research & Development

Operating Expenses

6,393

-524

3,277

2,321

1,319

-685

Other Non Operating Income (Expenses)

Pretax Income

-21

665

-400

-358

189

Income Tax Expense

-166

-172

-19

Net Income

644

-435

-215

168

Net Income Growth

-554%

283%

1,143%

-164%

-113.99%

-36%

Shares Outstanding (Diluted)

70.29

69.74

68.57

70.27

71.93

Shares Change (YoY)

-2%

-5%

-9%

-6%

-7%

EPS (Diluted)

0.83

9.16

-6.23

-3.13

0.92

2.33

EPS Growth

-561%

292%

1,209%

-170%

-113.99%

-32%

Free Cash Flow

5,885

1,849

1,045

1,621

1,370

1,173

Free Cash Flow Per Share

Gross Margin

Operating Margin

0.97%

526.01%

-7.47%

-18.56%

0.97%

-114.73%

Profit Margin

0.9%

523.57%

-14.26%

-10.81%

4.87%

-52.66%

Free Cash Flow Margin

90.65%

1,503.25%

34.27%

81.53%

102.85%

-367.71%

EBITDA

EBITDA Margin

D&A For EBITDA

EBIT

647

-228

-369

366

EBIT Margin

0.97%

526.01%

-7.47%

-18.56%

0.97%

-114.73%

Effective Tax Rate

790.47%

0.75%

-5%

48.04%

-26.38%

2.11%

Follow-Up Questions

What are Akeso, Inc.'s key financial statements?



According to the latest financial statement (Form-10K), Jackson Financial Inc has a total asset of $0, Net loss of $0

What are the key financial ratios for AKESF?



Jackson Financial Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Akeso, Inc.'s revenue broken down by segment or geography?



Currently Jackson Financial Inc data is not available.

Is Akeso, Inc. profitable?



no, according to the latest financial statements, Jackson Financial Inc has a net loss of $0

Does Akeso, Inc. have any liabilities?



no, Jackson Financial Inc has liability of 0

How many outstanding shares for Akeso, Inc.?



Jackson Financial Inc has a total outstanding shares of 0

Akeso, Inc. (AKESF) Financial

AKESF Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is AKESO INC.?

Akeso, Inc. (AKESF) Financial

AKESF Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is AKESO INC.?

AKESF Income

Follow-Up Questions

What are Akeso, Inc.'s key financial statements?

What are the key financial ratios for AKESF?

How is Akeso, Inc.'s revenue broken down by segment or geography?

Is Akeso, Inc. profitable?

Does Akeso, Inc. have any liabilities?

How many outstanding shares for Akeso, Inc.?